Insider · CIK 0001186123

HANSEN JOHN DAVID

Reports to the SEC for 2 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001186123

Forms 4 and 5

Insider transactions

45 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-04-02	MABVAX THERAPEUTICS HOLDINGS, INC.M Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	+13.6K sh	—	—	195,516
2018-04-02	MABVAX THERAPEUTICS HOLDINGS, INC.F Tax Payment	Director, PRESIDENT AND CEO	FTax Payment	−4,689 sh	—	—	190,827
2018-04-02	MABVAX THERAPEUTICS HOLDINGS, INC.Restricted Stock UnitM Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	−13.6K sh	—	—	0
2018-02-21	MABVAX THERAPEUTICS HOLDINGS, INC.Option to Purchase Common StockA Award	Director, PRESIDENT AND CEO	AAward	+290K sh	—	—	290,000
2018-01-16	MABVAX THERAPEUTICS HOLDINGS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−59.3K sh	$0.92	−$54.5K	536,730
2018-01-12	MABVAX THERAPEUTICS HOLDINGS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−18.6K sh	$0.96	−$17.8K	595,993
2018-01-11	MABVAX THERAPEUTICS HOLDINGS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−64K sh	$0.98	−$62.7K	614,575
2018-01-10	MABVAX THERAPEUTICS HOLDINGS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−110K sh	$0.96	−$106K	678,590
2018-01-08	MABVAX THERAPEUTICS HOLDINGS, INC.M Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	+727K sh	—	—	788,683
2018-01-08	MABVAX THERAPEUTICS HOLDINGS, INC.Restricted Stock UnitM Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	−727K sh	—	—	0
2017-10-02	MABVAX THERAPEUTICS HOLDINGS, INC.Restricted Stock UnitA Award	Director, PRESIDENT AND CEO	AAward	+551K sh	—	—	551,156
2017-09-15	MABVAX THERAPEUTICS HOLDINGS, INC.Restricted Stock UnitA Award	Director, PRESIDENT AND CEO	AAward	+176K sh	—	—	176,054
2017-05-19	MABVAX THERAPEUTICS HOLDINGS, INC.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+4,286 sh	$1.75	+$7,500.5	65,759
2017-05-19	MABVAX THERAPEUTICS HOLDINGS, INC.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+4,842 sh	—	—	70,601
2017-05-19	MABVAX THERAPEUTICS HOLDINGS, INC.Class A WarrantS Sale	Director, PRESIDENT AND CEO	SSale	−3,119 sh	—	—	0
2017-05-19	MABVAX THERAPEUTICS HOLDINGS, INC.Class B WarrantS Sale	Director, PRESIDENT AND CEO	SSale	−3,119 sh	—	—	0
2017-05-19	MABVAX THERAPEUTICS HOLDINGS, INC.Option to Purchase Common StockA Award	Director, PRESIDENT AND CEO	AAward	+500K sh	$2.00	+$1M	500,000
2017-04-12	MABVAX THERAPEUTICS HOLDINGS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−10.2K sh	$2.00	−$20.4K	61,473
2017-04-11	MABVAX THERAPEUTICS HOLDINGS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−250 sh	$2.00	−$500	71,689
2017-04-10	MABVAX THERAPEUTICS HOLDINGS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−560 sh	$2.00	−$1,120	71,939
2017-04-07	MABVAX THERAPEUTICS HOLDINGS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−666 sh	$2.00	−$1,335.33	72,499
2017-04-06	MABVAX THERAPEUTICS HOLDINGS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−1,501 sh	$2.15	−$3,223.398	73,165
2017-04-05	MABVAX THERAPEUTICS HOLDINGS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−2,450 sh	$2.15	−$5,270.685	74,666
2017-04-04	MABVAX THERAPEUTICS HOLDINGS, INC.S Sale	Director, PRESIDENT AND CEO	SSale	−1,100 sh	$2.25	−$2,475	77,116
2017-04-02	MABVAX THERAPEUTICS HOLDINGS, INC.M Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	+40.7K sh	—	—	78,216
2017-04-02	MABVAX THERAPEUTICS HOLDINGS, INC.Restricted Stock UnitM Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	−40.7K sh	—	—	40,687
2017-02-06	MABVAX THERAPEUTICS HOLDINGS, INC.Option to Purchase Common StockA Award	Director, PRESIDENT AND CEO	AAward	+250K sh	$2.99	+$748K	250,000
2017-01-01	MABVAX THERAPEUTICS HOLDINGS, INC.Option to Purchase Common StockA Award	Director, PRESIDENT AND CEO	AAward	+63.4K sh	$3.38	+$214K	63,400
2016-08-29	MABVAX THERAPEUTICS HOLDINGS, INC.Option to Purchase Common StockA Award	Director, PRESIDENT AND CEO	AAward	+63.4K sh	$5.00	+$317K	63,400
2016-08-17	MABVAX THERAPEUTICS HOLDINGS, INC.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+3,119 sh	—	—	37,529
2016-08-17	MABVAX THERAPEUTICS HOLDINGS, INC.Class A WarrantP Purchase	Director, PRESIDENT AND CEO	PPurchase	+3,119 sh	—	—	3,119
2016-08-17	MABVAX THERAPEUTICS HOLDINGS, INC.Class B WarrantP Purchase	Director, PRESIDENT AND CEO	PPurchase	+3,119 sh	—	—	3,119
2016-04-04	MABVAX THERAPEUTICS HOLDINGS, INC.M Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	+301K sh	—	—	367,782
2016-04-04	MABVAX THERAPEUTICS HOLDINGS, INC.F Tax Payment	Director, PRESIDENT AND CEO	FTax Payment	−113K sh	—	—	254,634
2016-04-04	MABVAX THERAPEUTICS HOLDINGS, INC.Restricted Stock UnitM Exercise/Conversion	Director, PRESIDENT AND CEO	MExercise/Conversion	−301K sh	—	—	602,166
2016-02-16	MABVAX THERAPEUTICS HOLDINGS, INC.Option to Purchase Common StockA Award	Director, PRESIDENT AND CEO	AAward	+500K sh	$0.49	+$245K	500,000
2015-04-02	MABVAX THERAPEUTICS HOLDINGS, INC.Option to Buy Common StockA Award	Director, PRESIDENT AND CEO	AAward	+903K sh	$2.30	+$2.08M	903,250
2015-04-02	MABVAX THERAPEUTICS HOLDINGS, INC.Restricted Stock UnitA Award	Director, PRESIDENT AND CEO	AAward	+903K sh	—	—	903,250
2005-01-03	AVANIR PHARMACEUTICALS, INC.S Sale	V.P. of Corporate Development	SSale	−14.4K sh	$3.41	−$49K	15,600
2005-01-03	AVANIR PHARMACEUTICALS, INC.S Sale	V.P. of Corporate Development	SSale	−600 sh	$3.42	−$2,052	15,000
2005-01-03	AVANIR PHARMACEUTICALS, INC.S Sale	V.P. of Corporate Development	SSale	−4,800 sh	$3.39	−$16.3K	25,200
2005-01-03	AVANIR PHARMACEUTICALS, INC.S Sale	V.P. of Corporate Development	SSale	−10.2K sh	$3.40	−$34.7K	15,000
2004-09-13	AVANIR PHARMACEUTICALS, INC.S Sale	V.P. of Corporate Development	SSale	−15K sh	$3.15	−$47.3K	30,000
2004-09-13	AVANIR PHARMACEUTICALS, INC.S Sale	V.P. of Corporate Development	SSale	−15K sh	$3.15	−$47.3K	30,000
2004-04-06	AVANIR PHARMACEUTICALS, INC.Incentive Stock Option (right to buy)A Award	V.P. of Corporate Development	AAward	+10K sh	—	—	10,000

Recent filings

Accepted (ET)
Apr 34
HANSEN JOHN DAVID0001415889-18-000537
SEC(opens sec.gov)
Feb 234
HANSEN JOHN DAVID0001415889-18-000310
SEC(opens sec.gov)
Jan 184
HANSEN JOHN DAVID0001415889-18-000082
SEC(opens sec.gov)
Jan 164
HANSEN JOHN DAVID0001415889-18-000060
SEC(opens sec.gov)
Oct 44
HANSEN JOHN DAVID0001415889-17-001611
SEC(opens sec.gov)
Sep 184
HANSEN JOHN DAVID0001415889-17-001499
SEC(opens sec.gov)
Aug 24
HANSEN JOHN DAVID0001415889-17-001297
SEC(opens sec.gov)
May 234
MABVAX THERAPEUTICS HOLDINGS, INC.0001415889-17-000839
SEC(opens sec.gov)
Apr 144
MABVAX THERAPEUTICS HOLDINGS, INC.0001415889-17-000638
SEC(opens sec.gov)
Apr 114
MABVAX THERAPEUTICS HOLDINGS, INC.0001415889-17-000634
SEC(opens sec.gov)

Companies

Address

11588 SORRENTO VALLEY ROAD, SUITE 20

SAN DIEGO, CA, 92121